Search research articles
Contact Us
Filters
Showing results (121-130 of 210) with videos related to
Page
of 21
Sort By:
Frontiers in Psychiatry
|
November 7, 2022
Learnings from user feedback of a novel digital mental health assessment
Erin Lucy Funnell, Benedetta Spadaro, Jiri Benacek, et al.
Genome Medicine
|
March 28, 2013
Proteomic profiling in schizophrenia: enabling stratification for more effective treatment
Paul C Guest, Daniel Martins-de-Souza, Emanuel Schwarz, et al.
Molecular Psychiatry
|
December 23, 2021
Novel open reading frames in human accelerated regions and transposable elements reveal new leads to understand schizophrenia and bipolar disorder
Chaitanya Erady, Krishna Amin, Temiloluwa O A E Onilogbo, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
December 16, 2011
Differential phosphorylation of serum proteins reflecting inflammatory changes in schizophrenia patients
Julian A J Jaros, Daniel Martins-de-Souza, Hassan Rahmoune, et al.
Journal of Proteomics
|
March 3, 2012
Clinical use of phosphorylated proteins in blood serum analysed by immobilised metal ion affinity chromatography and mass spectrometry
Julian A J Jaros, Paul C Guest, Hassan Ramoune, et al.
Journal of Proteomics
|
May 30, 2012
Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls
Julian A J Jaros, Daniel Martins-de-Souza, Hassan Rahmoune, et al.
JMIR Research Protocols
|
January 8, 2021
The Current State and Diagnostic Accuracy of Digital Mental Health Assessment Tools for Psychiatric Disorders: Protocol for a Systematic Review and Meta-analysis
Nayra A Martin-Key, Thea S Schei, Eleanor J Barker, et al.
Psychoneuroendocrinology
|
February 11, 2018
Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis
Maximus Berger, Robert-Paul Juster, Sabine Westphal, et al.
Plos One
|
August 2, 2007
Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms
Rachel M Craddock, Helen E Lockstone, David A Rider, et al.
Proteomics. Clinical Applications
|
October 19, 2011
Proteomic changes induced by anaesthesia and muscle relaxant treatment prior to electroconvulsive therapy
Viktoria Stelzhammer, Matthias Rothermundt, Paul C Guest, et al.
Page
of 21
Search research articles
Search
Showing results (121-130 of 210) with videos related to
Sort By:
Page
of 21
Frontiers in Psychiatry
|
November 7, 2022
Learnings from user feedback of a novel digital mental health assessment
Erin Lucy Funnell, Benedetta Spadaro, Jiri Benacek, et al.
Genome Medicine
|
March 28, 2013
Proteomic profiling in schizophrenia: enabling stratification for more effective treatment
Paul C Guest, Daniel Martins-de-Souza, Emanuel Schwarz, et al.
Molecular Psychiatry
|
December 23, 2021
Novel open reading frames in human accelerated regions and transposable elements reveal new leads to understand schizophrenia and bipolar disorder
Chaitanya Erady, Krishna Amin, Temiloluwa O A E Onilogbo, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
December 16, 2011
Differential phosphorylation of serum proteins reflecting inflammatory changes in schizophrenia patients
Julian A J Jaros, Daniel Martins-de-Souza, Hassan Rahmoune, et al.
Journal of Proteomics
|
March 3, 2012
Clinical use of phosphorylated proteins in blood serum analysed by immobilised metal ion affinity chromatography and mass spectrometry
Julian A J Jaros, Paul C Guest, Hassan Ramoune, et al.
Journal of Proteomics
|
May 30, 2012
Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls
Julian A J Jaros, Daniel Martins-de-Souza, Hassan Rahmoune, et al.
JMIR Research Protocols
|
January 8, 2021
The Current State and Diagnostic Accuracy of Digital Mental Health Assessment Tools for Psychiatric Disorders: Protocol for a Systematic Review and Meta-analysis
Nayra A Martin-Key, Thea S Schei, Eleanor J Barker, et al.
Psychoneuroendocrinology
|
February 11, 2018
Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis
Maximus Berger, Robert-Paul Juster, Sabine Westphal, et al.
Plos One
|
August 2, 2007
Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms
Rachel M Craddock, Helen E Lockstone, David A Rider, et al.
Proteomics. Clinical Applications
|
October 19, 2011
Proteomic changes induced by anaesthesia and muscle relaxant treatment prior to electroconvulsive therapy
Viktoria Stelzhammer, Matthias Rothermundt, Paul C Guest, et al.
Page
of 21